Supernus Pharmaceuticals, Inc. today announced the initiation of a Phase IIa U.S. clinical trial of its product candidate SPN810 in the treatment of serious conduct problems in the setting of ADHD. The trial is a proof-of-concept, open-label study with pediatric subjects randomized according to weight group and titrated to receive one of four doses over a six-week treatment period. The primary ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Shire PLC (Nasdaq: SHPGY), O'Reilly Automotive, Inc. (Nasdaq: ORLY), Burlington Northern Santa Fe Corp. (NYSE: BNI), United Therapeutics Corp. (Nasdaq: UTHR) ...

The 2008 Mid-Atlantic Bio takes place October 22, 2008 - October 24, 2008 at the Westfields Marriott Washington Dulles in Chantilly. Listed below are the 2008 Mid-Atlantic Bio exhibitor profiles.